NeuroOne® to Report Third Quarter Fiscal Year 2022 Financial Results on August 11 – Marketscreener.com

Related Articles:

• The road ahead: 2022 January 20, 2022 # # # # The first post at the start of each year on the SoPD website tries to provide an overview of where things are in the search for ‘disease modifying’ therapies for Parkinson’s.  It is an exercise in managing expectations as well as discussing what research events are scheduled for the next year so that we can keep…
• NeuroOne Medical Technologies Corporation: Announces Fiscal Third Quarter 2019 Financial Results and Provides a Corporate Update - Yahoo Finance August 14, 2019 NeuroOne Medical Technologies Corporation: Announces Fiscal Third Quarter 2019 Financial Results and Provides a Corporate Update  Yahoo FinanceMINNETONKA, MN / ACCESSWIRE / August 14, 2019 / NeuroOne Medical Technologies Corporation (NMTC), a medical device company focused on the ...
• Monthly Research Review – August 2019 August 31, 2019   At the end of each month the SoPD writes a post which provides an overview of some of the major pieces of Parkinson’s-related research that were made available during August 2019. The post is divided into seven parts based on the type of research: Basic biology Disease mechanism Clinical research New clinical trials Clinical trial news Other news Review…
• 2020: Year in Review January 1, 2021 # # # # In this end-of-year post, we review the Parkinson’s research that caught our attention at SoPD HQ in 2020. Month-by-month we will briefly discuss some of the major pieces of research/ announcements that have defined the year and advanced our understanding of Parkinson’s. The list is based on nothing more than the author’s personal opinion – apologies…
• NeuroOne Medical Technologies : ® Issues Letter to Stockholders in Connection With 2022 Annual Meeting of Stockholders - Form 8-K - Marketscreener.com June 2, 2022 NeuroOne Medical Technologies : ® Issues Letter to Stockholders in Connection With 2022 Annual Meeting of Stockholders - Form 8-K  Marketscreener.com
• 7 Legal and Financial Tips to Plan a Better Life with Parkinson’s March 5, 2019 The first concern for most people following a Parkinson’s disease (PD) diagnosis is to get the right medical help. Next, many people begin planning for living their life with Parkinson’s ensuring that their legal, financial and insurance concerns are all in good shape. While earning ability or other sources of cash flow may change, with planning and a better understanding of the…
• 2019: Year in review December 31, 2019   In this end-of-year post, we review the Parkinson’s research that caught our attention at SoPD HQ in 2019. Month-by-month we will briefly discuss some of the major pieces of research/announcements that have defined the year and advanced our understanding of Parkinson’s. The list is based on nothing more than the author’s personal opinion – apologies to any researchers who…
• The road ahead: 2021 January 25, 2021 # # # # At the start of each year, it is a useful practise to layout what is planned over the next 12 months. The events that are scheduled for the year to come, so that we can keep an eye out for them. Obviously, where 2021 will end actually is unpredictable, but an outline of what is scheduled…
• Anavex Life Sciences to Announce Fiscal 2021 Year End Financial Results on Wednesday, November 24, 2021 - marketscreener.com November 17, 2021 Anavex Life Sciences to Announce Fiscal 2021 Year End Financial Results on Wednesday, November 24, 2021  marketscreener.com
• Monthly research review: February 2020 February 29, 2020   At the end of each month the SoPD writes a post which provides an overview of some of the major pieces of Parkinson’s-related research that were made available during February 2020. The post is divided into seven parts based on the type of research: Basic biology Disease mechanism Clinical research New clinical trials Clinical trial news Other news Review…
• Year in review: 2021 December 31, 2021 # # # # As with the preceding year, 2021 proved to be challenging due to the continuing COVID-19 pandemic (and it is not over yet). Vaccines were rolled out with remarkable speed, but equally new variants of the virus popped up and have kept Governments and health regulatory bodies on their toes. An amazing feature of the last two…
• Anavex Life Sciences to Announce Fiscal 2019 Third Quarter Financial Results on Wednesday, August 7th, 2019 - Yahoo Finance August 2, 2019 Anavex Life Sciences to Announce Fiscal 2019 Third Quarter Financial Results on Wednesday, August 7th, 2019  Yahoo FinanceConference Call and Webcast To be Held Wednesday, August 7, 2019 4:30 p.m. Eastern Time. NEW YORK, Aug. 02, 2019 (GLOBE NEWSWIRE) -- Anavex Life ...
• PharmaTher Reports Financial Results for the Third Quarter of Fiscal 2022 and Provides Recent Business Highlights and Update - GlobeNewswire April 25, 2022 PharmaTher Reports Financial Results for the Third Quarter of Fiscal 2022 and Provides Recent Business Highlights and Update  GlobeNewswire
• Anavex Life Sciences Provides Business Update and Reports Fiscal 2022 Third Quarter Financial Results - GlobeNewswire August 9, 2022 Anavex Life Sciences Provides Business Update and Reports Fiscal 2022 Third Quarter Financial Results  GlobeNewswire
• Monthly Research Review – November 2019 November 30, 2019   At the end of each month the SoPD writes a post which provides an overview of some of the major pieces of Parkinson’s-related research that were made available during November 2019. The post is divided into seven parts based on the type of research: Basic biology Disease mechanism Clinical research New clinical trials Clinical trial news Other news Review…
• Anavex Life Sciences Reports Fiscal 2019 Third Quarter Financial Results And Provides Clinical Study Updates - GlobeNewswire August 7, 2019 Anavex Life Sciences Reports Fiscal 2019 Third Quarter Financial Results And Provides Clinical Study Updates  GlobeNewswireNEW YORK, Aug. 07, 2019 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage ...
• Sio Gene Therapies Announces Financial Results for Third Fiscal Quarter Ended December 31, 2020 - GlobeNewswire February 9, 2021 Sio Gene Therapies Announces Financial Results for Third Fiscal Quarter Ended December 31, 2020  GlobeNewswire
• Sio Gene Therapies Announces Financial Results for Third Fiscal Quarter Ended December 31, 2020 - BioSpace February 9, 2021 Sio Gene Therapies Announces Financial Results for Third Fiscal Quarter Ended December 31, 2020  BioSpace
• Anavex Life Sciences Provides Business Update and Reports Fiscal 2021 Third Quarter Financial Results - GlobeNewswire August 12, 2021 Anavex Life Sciences Provides Business Update and Reports Fiscal 2021 Third Quarter Financial Results  GlobeNewswire
• NeuroOne Featured on The Medical Alley Podcast: "A Conversation with Dave Rosa, President and CEO, NeuroOne" - Yahoo Finance December 20, 2021 NeuroOne Featured on The Medical Alley Podcast: "A Conversation with Dave Rosa, President and CEO, NeuroOne"  Yahoo Finance
• Anavex Life Sciences to Announce Fiscal 2021 Third Quarter Financial Results on Thursday, August 12, 2021 - Yahoo Finance August 5, 2021 Anavex Life Sciences to Announce Fiscal 2021 Third Quarter Financial Results on Thursday, August 12, 2021  Yahoo Finance
• Axovant Announces Corporate Updates and Financial Results for First Fiscal Quarter Ended June 30, 2019 - GlobeNewswire August 9, 2019 Axovant Announces Corporate Updates and Financial Results for First Fiscal Quarter Ended June 30, 2019  GlobeNewswireSUNRISE-PD Phase 2 trial of AXO-LENTI-PD for Parkinson's disease continues to enroll patients in second dose cohort with data expected in the fourth quarter ...